This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Landiolol, sold under the brand name Rapiblyk, is only meant to be administered in a hospital setting. It was initially approved for adult patients in 2024.
Almost 15% of more than 5,500 U.S. adults—representing around 14 million individuals—have skipped a doctor visit after feeling satisfied enough with health advice they received from AI.
Demonstrated cost-effectiveness is a highly motivating factor in getting healthcare workers to adopt measures for preventing and controlling healthcare-associated infections.
Some FDA-approved medical devices age more safely than others. That’s no less true of AI-enabled technologies than of any others. The agency spells out the ramifications in draft guidance issued this week.
The popular GLP-1 receptor agonist appears to help limit adverse events and new-onset diabetes in patients with a history of CABG. Researchers shared the full study in the Journal of the American College of Cardiology.